| Particulars |
| Company Name |
Natco Pharma Ltd |
| Face Value |
2 |
| BSE Code |
524816 |
| Year End |
202503 |
| Full Year |
| Equity (Rs in Cr.) |
35.82 |
| B.V. Rs |
461.80 |
| Sales Rs in Cr. |
4,094.50 |
| NP Rs in Cr. |
1,778.18 |
| NP Var% |
36.00 |
| Div% |
300.00 |
| CPS Rs |
111.60 |
| EPS Rs |
99.30 |
| Traded Value(Rs in Lakhs) |
14,695.67 |
| 52 Week High |
1,504.00 |
| 52 Week Low |
660.00 |
| Price BSE |
927.00 |
| Price NSE |
927.00 |
| Market Capital(Rs in Cr.) |
16,601.69 |
| P/C Ratio |
8.30 |
| P/E Ratio |
9.30 |
| Price Vs.BV |
2.01 |
| Latest Quarter |
| Year End |
202509 |
| Sales Rs in Cr. |
1,264.30 |
| NP Rs in Cr. |
500.90 |
| NP Var % |
-24.00 |
| Trailing Twelve Months |
| Year End |
202509 |
| Sales |
4,119.60 |
| OPM |
54.49 |
| NP |
1,838.50 |
| NP Var% |
-17.43 |
| EPS |
84.75 |
| PE |
10.94 |
|